Effects of zileuton and montelukast in mouse experimental spinal cord injury.
about
CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancerA potential protective effect of alpha-tocopherol on vascular complication in spinal cord reperfusion injury in rats.Glucocorticoid-induced leucine zipper (GILZ) over-expression in T lymphocytes inhibits inflammation and tissue damage in spinal cord injury.The dual cyclooxygenase/5-lipoxygenase inhibitor licofelone attenuates p-glycoprotein-mediated drug resistance in the injured spinal cord.Licofelone modulates neuroinflammation and attenuates mechanical hypersensitivity in the chronic phase of spinal cord injuryEfficacy of iloprost and montelukast combination on spinal cord ischemia/reperfusion injury in a rat model.Role of phospholipase A2s and lipid mediators in secondary damage after spinal cord injury.Cysteinyl leukotrienes as novel host factors facilitating Cryptococcus neoformans penetration into the brain.Neutrophil swarming toward Cryptococcus neoformans is mediated by complement and leukotriene B4.The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophagesThe protective role of montelukast against intestinal ischemia-reperfusion injury in rats.The effects of zileuton and montelukast in reperfusion-induced arrhythmias in anesthetized rats.Inhibition of 5-lipoxygenase by zileuton in a rat model of myocardial infarction.Cysteinyl-leukotriene receptor antagonist montelukast decreases blood-brain barrier permeability but does not prevent oedema formation in traumatic brain injury.Metformin ameliorates BSCB disruption by inhibiting neutrophil infiltration and MMP-9 expression but not direct TJ proteins expression regulation.Docosahexaenoic acid, but not eicosapentaenoic acid, reduces the early inflammatory response following compression spinal cord injury in the rat.5-LOX Inhibitor Zileuton Reduces Inflammatory Reaction and Ischemic Brain Damage Through the Activation of PI3K/Akt Signaling Pathway.Role of Caspase-8 and Fas in Cell Death After Spinal Cord Injury.
P2860
Q28536784-0D638F29-1F6B-4519-BCE1-76C5C6B677E3Q34016604-F2230F46-36EE-4A69-B978-7B4F84B211BEQ35729623-E4B8A576-7ADD-4D4F-980A-882C3D31B3C4Q36590671-A1F80E99-BC96-4759-A11F-BBA6A17D1111Q36650424-40066EA0-ABE9-45D6-8078-47659B3609B5Q36805334-404042E8-88DA-475F-8A9F-13F49AB5E30BQ38009737-D0F58AA7-7296-46F1-876D-A76D6A796749Q40558798-256E296A-FBCA-43FF-96B5-74C9B818F8A3Q40617677-4E3B2183-7CDD-4218-BE66-3F4FF9E4A393Q41665336-F02321A9-2B46-421C-AEE6-F6D6BADB378CQ41856144-F912F0B8-A4A6-484D-B135-4796957B3EF6Q41883945-BC955121-EE0C-407A-9342-76B495DC5E9AQ42078106-3545DAD6-816F-4680-8A5C-BF7A711AB707Q45988519-5EE9F04E-EDF1-4459-9B85-C019C38929F6Q47126353-9859F55F-8420-4E50-96F9-FE169E19E992Q48622009-537A9B27-0337-4236-B81F-BB0182ED965FQ48638538-F598742D-C239-4DC3-8DD8-ABE155ECBC0EQ52581900-4A535A9B-EB73-4630-91B9-B65F1F93EC66
P2860
Effects of zileuton and montelukast in mouse experimental spinal cord injury.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Effects of zileuton and montelukast in mouse experimental spinal cord injury.
@en
Effects of zileuton and montelukast in mouse experimental spinal cord injury.
@nl
type
label
Effects of zileuton and montelukast in mouse experimental spinal cord injury.
@en
Effects of zileuton and montelukast in mouse experimental spinal cord injury.
@nl
prefLabel
Effects of zileuton and montelukast in mouse experimental spinal cord injury.
@en
Effects of zileuton and montelukast in mouse experimental spinal cord injury.
@nl
P2093
P2860
P356
P1476
Effects of zileuton and montelukast in mouse experimental spinal cord injury.
@en
P2093
L Sautebin
P Bramanti
R Caminiti
R Di Paola
S Cuzzocrea
T Genovese
P2860
P304
P356
10.1038/SJ.BJP.0707577
P407
P577
2007-12-03T00:00:00Z